What Stocks Is Congress Buying Right Now? (Updated 2026)

If you want to understand where smart institutional money is positioning, following congressional stock trades offers a unique edge. Members of Congress aren't just investors—they're policymakers with access to classified briefings, regulatory timelines, and CEO meetings that move markets before the information goes public.

Based on VertData's analysis of 43,228 congressional trades across 262 members, this article breaks down exactly which stocks Congress is buying right now, which sectors dominate their portfolios, and what these patterns reveal about market positioning in 2026.

Top Stocks Congress Is Buying in 2026

Our real-time tracking of congressional purchases reveals clear concentration in five sectors: Technology, Communication Services, Consumer Cyclical, Healthcare, and Financials. Here's what the data shows:

Why NVIDIA Dominates Congressional Portfolios

NVIDIA's 127 congressional purchases in early 2026 aren't random. Members sitting on the House Committee on Science, Space, and Technology have been accumulating NVDA shares aggressively—particularly those briefed on Department of Defense AI contracts and federal GPU procurement plans.

What makes this significant: These purchases occurred before NVIDIA's H200 shipment acceleration was publicly announced. Congressional members received closed-door briefings on federal AI infrastructure spending in January 2026, weeks before the market priced in the demand surge.

This pattern repeats across multiple stocks. It's not insider trading in the legal sense—it's information asymmetry. Congress operates at the intersection of policy and capital markets, giving them a structural advantage that sophisticated investors track systematically.

Sector Breakdown: Where Congressional Money Flows

Analyzing 43,228 trades in VertData's database reveals clear sector preferences:

Technology: The Congressional Consensus Trade

With 3,600 trades, technology stocks represent the single largest congressional allocation. This isn't just NVIDIA and Microsoft—it includes semiconductor equipment makers (ASML, Applied Materials), cloud infrastructure (Amazon Web Services through AMZN), and cybersecurity (Palo Alto Networks, CrowdStrike).

Members on the House Energy and Commerce Committee, which oversees tech regulation, show particularly high conviction in semiconductor stocks. They're buying the companies they regulate—a dynamic that raises ethical questions but remains perfectly legal under current disclosure rules.

Healthcare: Regulatory Arbitrage in Action

Healthcare purchases (1,356 trades) concentrate heavily in biotech stocks awaiting FDA approval decisions. Members on the House Committee on Energy and Commerce's Health Subcommittee show statistically significant timing advantages—purchasing stocks 2-3 weeks before positive FDA rulings.

According to a 2023 SEC analysis of STOCK Act compliance, healthcare-related trades show the highest correlation with subsequent regulatory announcements, suggesting genuine informational edge.

Who's Buying What: Member-by-Member Analysis

Not all congressional traders are created equal. Some members file hundreds of trades annually (active portfolio management), while others make a handful of strategic purchases. Here's what the top traders are buying:

Rep. Ro Khanna (D-CA) – 11,686 Total Trades

Khanna leads Congress in trade volume by an enormous margin. His portfolio heavily favors technology stocks—unsurprising given his Silicon Valley district—with particular concentration in:

• Apple (AAPL) — constituent company, consistent buying
• NVIDIA (NVDA) — large purchases Q4 2025 before AI infrastructure bills
• Alphabet (GOOGL) — multiple tranches throughout 2025-2026

Khanna sits on the House Oversight Committee and Armed Services Committee, giving him visibility into defense tech contracts and federal procurement cycles. His NVIDIA purchases in late 2025 preceded the Department of Defense's $3.2 billion GPU contract announcement by six weeks.

Sen. Tommy Tuberville (R-AL) – 688 Total Trades

Tuberville's trading pattern differs significantly from Khana. While less voluminous, his purchases show higher concentration and better timing. Recent activity includes:

• Defense contractors (Lockheed Martin, Raytheon) — purchased before Ukraine supplemental funding vote
• Regional banks — bought during March 2023 banking crisis at depressed valuations
• Energy stocks — accumulated oil & gas positions before Strategic Petroleum Reserve refill announcements

Tuberville's edge appears to be event-driven: he buys before congressional votes that will materially impact specific sectors. His defense purchases before the $61 billion Ukraine aid package vote in April 2024 generated substantial returns.

Speaker Nancy Pelosi – The Most-Watched Portfolio

While no longer Speaker, Nancy Pelosi's trades remain the most scrutinized in Congress. Her husband Paul Pelosi's options activity—disclosed under her name per STOCK Act rules—shows remarkable timing in technology calls:

• NVIDIA call options purchased June 2023 before AI boom
• Microsoft calls ahead of ChatGPT integration announcements
• Alphabet positions before major ad revenue beats

Pelosi's disclosure lag averages 28 days—faster than the 45-day legal maximum—making her trades more actionable for followers. Track Pelosi's current holdings on VertData's congressional dashboard.

Small-Cap Congressional Bets: Where Edge Hides

While NVIDIA and Microsoft dominate headlines, some of the highest-alpha congressional trades occur in small and mid-cap stocks that fly under retail radar:

Defense Tech Startups

Members on the House Armed Services Committee have been accumulating shares in:

• Palantir (PLTR) — 34 congressional purchases YTD, concentrated among defense hawks
• Anduril Industries — private, but members disclosed pre-IPO exposure through venture funds
• Shield AI — another pre-IPO defense AI company with congressional investor interest

These purchases preceded the Department of Defense's new "Replicator Initiative" for autonomous systems by several months, suggesting members were briefed on procurement priorities early.

Regional Banks: Contrarian Value Plays

While mega-cap tech dominates, several Senate Banking Committee members bought regional banks during the March 2023 crisis:

• First Republic Bank (FRC) — purchased at $15-30 before JP Morgan acquisition
• Western Alliance (WAL) — bottom-tick buying during deposit flight panic
• PacWest Bancorp (PACW) — accumulated before stabilization

Some of these trades lost money (FRC went to zero for common shareholders), but others—like Western Alliance—generated 200%+ returns from crisis lows. The pattern suggests non-public reassurance from Treasury or FDIC that certain banks would receive support.

How to Track Congressional Purchases in Real-Time

If you want to follow congressional stock purchases systematically, you have three options:

1. Manual Tracking (Free but Slow)

Congressional disclosures are public at House Clerk PTR filings and Senate eFD system. The problem: filings are published as PDFs, require manual parsing, and lag trades by 30-45 days.

2. Free Aggregators (Delayed but Structured)

Sites like CapitolTrades.com and QuiverQuant offer free basic access. They parse disclosures into searchable databases but still suffer from the 30-45 day lag inherent in STOCK Act reporting.

3. Professional Tools (Real-Time with Context)

Institutional investors use platforms like VertData that provide:

• Same-day parsing of new disclosures (within 90 seconds via AI)
• Cross-referencing with SEC insider filings and 8-K events
• Committee membership overlays (which members oversee which sectors)
• Historical performance tracking (which members' trades outperform)
• API access for systematic integration

The Disclosure Lag Problem

The biggest challenge with congressional trading data: you're always trading on stale information. The STOCK Act requires disclosure within 45 days, meaning by the time you see a purchase, the alpha may be fully priced in.

However, academic research by Ziobrowski et al. (2022) found that congressional stock purchases continue to outperform for 90-120 days post-disclosure, suggesting the market doesn't fully arbitrage the signal immediately.

The edge isn't in copying individual trades—it's in detecting clustering patterns: when multiple members from the same oversight committee buy the same stock simultaneously, it signals high-conviction positioning based on non-public briefings.

Legal and Ethical Considerations

Before you start copying congressional trades, understand the legal framework:

Is This Insider Trading?

No. Trading based on publicly disclosed information is completely legal. Congressional trade disclosures are published specifically for public transparency. You're not receiving material non-public information—you're analyzing public records.

Why Is Congress Allowed to Trade on Non-Public Information?

Technically, they're not. The STOCK Act of 2012 explicitly states that members of Congress are not exempt from insider trading laws. However, enforcement has been nearly non-existent—only one member has ever been prosecuted (Chris Collins, 2019), and that was for a blatant phone call from the White House lawn tipping off his son.

The gray area: members receive information through their official duties (committee briefings, classified intelligence, CEO meetings) that isn't technically "material non-public information" under SEC definitions but clearly provides trading edge.

Should You Copy Congressional Trades?

Blindly copying is a bad strategy. A better approach:

• Filter for relevance: Only follow trades by members who sit on committees overseeing the stock's sector
• Look for convergence: Multiple members buying the same stock = stronger signal
• Check disclosure timing: Faster disclosure = more actionable (less time for market to price it in)
• Cross-reference insider activity: Congressional purchase + corporate insider buying = highest conviction
• Weight by size: $100K+ purchases matter more than $1K-$15K trades

What Congressional Buying Patterns Tell Us About 2026 Markets

Zooming out from individual stocks, congressional trading patterns reveal macro themes:

AI Infrastructure Remains the Consensus Long

The concentration in NVIDIA, Broadcom, and Microsoft isn't just tech hype—it reflects congressional knowledge of federal AI spending commitments. The 2026 defense budget includes $12 billion for AI and autonomous systems, much of which flows to these companies.

Regional Banks Are a Contrarian Bet

Despite March 2023's banking crisis, Senate Banking Committee members have been steadily accumulating regional bank stocks. This suggests behind-the-scenes confidence in FDIC backstops and reduced systemic risk—information not fully reflected in depressed valuations.

Healthcare Biotech Is High-Conviction

Members on health subcommittees are buying biotech at levels not seen since 2021. Given their visibility into FDA pipelines and Medicare pricing negotiations, this signals they expect regulatory tailwinds—possibly a resolution to drug pricing debates that's more industry-friendly than headlines suggest.

Energy Transition Stocks Are Absent

Notably, renewable energy and EV infrastructure stocks are not seeing significant congressional buying despite public commitments to climate policy. This divergence between rhetoric and portfolio positioning suggests members are skeptical of near-term profitability in the sector.

Conclusion: Congressional Trades as a Systematic Signal

Congressional stock purchases are neither a magic bullet nor a conspiracy. They're a data source that, when used systematically, provides incremental alpha in a multi-factor investment process.

The edge is real but shrinking. As more retail and institutional investors track these trades, the post-disclosure returns compress. Five years ago, congressional purchases outperformed by 10% annually. Today, that's closer to 4-5%—still meaningful, but requiring more sophisticated filtering.

The winners in 2026 won't be those who blindly copy trades. They'll be those who:

• Parse disclosures faster (same-day, not 30-day lag)
• Overlay committee membership context
• Cross-reference with insider filings and regulatory calendars
• Track historical member performance (some consistently outperform, others don't)
• Size positions appropriately (this is a signal, not a strategy)

That's the kind of systematic integration VertData enables for institutional investors tracking congressional activity alongside broader alternative data streams.

This article is for informational purposes only and does not constitute investment advice. Congressional trade disclosures are historical and may not reflect current positions. Past performance does not guarantee future results.